Hoda Anton-Culver, PhD
College of Medicine
University of California-Irvine
Dr. Anton-Culver’s research is in the broad scientific areas of cancer epidemiology and cancer genetics. Her research focuses on cancer epidemiology with special emphasis on etiology, molecular genetic characterization, evaluation of genetic-phenotype correlation, and genotype-environment interaction using large populations of cancer patients, their relatives, and unaffected controls. She has been at UC Irvine for over thirty-two years and has established major research programs in cancer epidemiology and cancer genetic. It was during the California Cancer Registries Annual Meeting that Dr. Anton-Culver came in contact with CBTRUS and joined the CBTRUS Advisory Board.
Melissa Bondy, PhD
Chair and Professor, Epidemiology and Population Health
Assistant Director, Population Sciences
Stanford Cancer Center
Dr. Melissa Bondy is the inaugural chair of the Department of Epidemiology and Population Health and the Associate Director for Population Sciences at the Stanford Cancer Institute. Her research focus is in genetic and molecular epidemiology of cancer and outcomes, primarily brain and breast cancer. She leads the largest family study of glioma patients, as well as a study of molecular predictors of outcome for glioma patients. Dr. Bondy serves on the National Cancer Institute’s (NCI) Board of Scientific Advisors, where she provides direct counsel to the Director of the NCI, and is a member of the External Advisory Board for several NCI-designated cancer centers. In 2018, she received the Visiting Scholar Award from the NCI Division of Cancer Epidemiology and Genetics. She is a founding member of the CBTRUS Advisory Board.
Elizabeth Claus, MD, PhD
Yale University School of Medicine
New Haven, CT
Brigham and Women’s Hospital
Dr. Claus is Professor and Director of Medical Research in the Yale University School of Public Health as well as Attending Neurosurgeon and Director of Stereotactic Radiosurgery within the Department of Neurosurgery at Brigham and Women’s Hospital in Boston. Her work is focused in cancer and genetic epidemiology with an emphasis on the development of risk models for breast and brain tumors. She is the overall Principal Investigator of the Meningioma Consortium, the Meningioma Genome-Wide Association Study, and the Yale Acoustic Neuroma Study as well as a co-investigator of the GLIOGENE (Genes for Glioma) and International Glioma Case/Control (GICC) projects. In addition to her research activities, Dr. Claus trained as a neurosurgeon at Yale-New Haven Hospital and completed a fellowship in neurosurgical oncology at Brigham and Women’s Hospital; her clinical focus is on the treatment of meningioma, glioma, acoustic neuroma and brain metastases. In partnership with national patient brain tumor organizations including the American Brain Tumor Association (ABTA), the National Brain Tumor Society (NBTS) and the Acoustic Neuroma Association (ANA), Dr. Claus is working to develop cost- and time-efficient web- and smartphone- based recruitment strategies to be used in the study of brain tumors.
Jennifer Cullen, PhD, MPH
Associate Director for Cancer Population Science
Case Comprehensive Cancer Center
Professor, Population and Quantitative Health Sciences
Case Western Reserve University School of Medicine
Jennifer Cullen PHD, MPH is the Associate Director for Cancer Population Science at the Case Comprehensive Cancer Center (CCC) and Professor in the Department of Population and Quantitative Health Sciences at the Case Western Reserve University (CWRU) School of Medicine. As Associate Director, Dr. Cullen oversees the broad interests and approaches taken by members of the Case CCC, its consortium institutions, and research members in all aspects of cancer population sciences. Previously, she was Interim Co-Director and Director of the Epidemiologic Research Program of the Department of Defense and Associate Professor at the Uniformed Services University of Health Sciences. Dr. Cullen was instrumental in the identification and validation of biomarkers and assay panels to forecast prostate cancer outcomes. She is a member of the Brain Tumor Epidemiology Consortium and in April 2020 agreed to serve on the CBTRUS Advisory Board.
Faith Davis, PhD
School of Public Health
University of Alberta
Dr. Davis graduated from Yale University with a PhD in Chronic Disease Epidemiology after receiving both a Master in Public Health and a Masters in Public Administration from Harvard. She served as research Professor in the Division of Epidemiology and Biostatistics at the School of Public Health at the University of Illinois at Chicago (UIC) before returning to her native Canada to accept a position as Professor and Vice-Dean of the School of Public Health at the University of Edmonton. She is currently Professor Emerita. Dr. Davis served as the Scientific Principal Investigator for CBTRUS while at the UIC School of Public Health for many years. She is currently exploring how best to provide epidemiologic data on all primary brain tumors and other rare cancers for the Canadian population and provided the scientific expertise to help found the Brain Tumor Registry of Canada while supporting expansion of the excellent teaching and research programs at the U of Alberta School of Public Health.
Roberta McKean-Cowdin, PhD
Department of Epidemiology
University of Southern California
Los Angeles, CA
Dr. McKean-Cowdin is an Associate Professor of Clinical Preventive Medicine in the Department of Epidemiology at the University of Southern California. After receiving her doctorate she became interested in brain tumors when working with renowned epidemiologist Dr. Susan Preston-Martin. She is currently focused on the epidemiology of breast cancer, including the role of endogenous sex hormones and hormone replacement therapy and the epidemiology of childhood brain tumors, including developmental genetics.
John Villano, MD, PhD.
Division of Medical Oncology
University of Kentucky
Markey Cancer Center
Dr. Villano is the Director of the University of Kentucky HealthCare’s Clinical Neuro-Oncology Research Program where he specialized in brain tumor care and research. Previously, Dr. Villano served as the director of medical neuro-oncology at the University of Illinois Medical Center. He earned a medical degree and doctor of philosophy at the University of Texas Southwestern Medical School at Dallas and trained in neurology at the University of Michigan. He also completed a fellowship in hematology/oncology at the University of Chicago. He is a former American Society of Clinical Oncology track leader for CNS tumors, a member of the Neuro-Oncology Committee in the cooperative group ALLIANCE and a Society of Neuro-Oncology committee member. Dr. Villano has collaborated with CBTRUS on many projects. Along with CBTRUS President Carol Kruchko he serves on the Board of Advisors of the Brain Tumor Epidemiology Consortium.